No price series to chart for NEPH.
NEPH is not in the screener universe; fundamentals are unavailable.
No price history for NEPH — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for NEPH, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| SYK | STRYKER CORP | $132.87B | 41.3 |
| MMM | 3M CO | $94.11B | 30.4 |
| BSX | BOSTON SCIENTIFIC CORP | $68.46B | 23.7 |
| BDX | BECTON DICKINSON & CO | $45.83B | 28.6 |
| MDLN | Medline Inc. | $32.81B | — |
| RMD | RESMED INC | $30.31B | 22.0 |
| DXCM | DEXCOM INC | $28.88B | 35.8 |
| WST | WEST PHARMACEUTICAL SERVICES INC | $23.72B | 49.6 |
| SOLV | Solventum Corp | $14.92B | 9.7 |
| MODD | Modular Medical, Inc. | $12.67B | — |
| BAX | BAXTER INTERNATIONAL INC | $12.59B | — |
| PEN | Penumbra Inc | $12.59B | 70.8 |
